Why CMC Is Becoming the Competitive Advantage in Biotech
June 24, 2026
BioProcess Theatre
Type: BioProcess Session
• How investors evaluate manufacturing risks
• Common CMC mistakes that delay value inflection
• Designing development programs for commercial success
• Building manufacturability into the molecule early
Speakers
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}